Yao, Zhiping
Zhou, Jingxin
Li, Shuying
Zhou, Wenqin
Article History
Received: 28 August 2022
Accepted: 7 November 2022
First Online: 15 November 2022
Declarations
:
: Ethical approval was obtained from China Ethics Committee of Registering Clinical Trials (ChiECRCT20190194), address: West China Hospital, Sichuan University, NO. 37, Guo Xue Xiang, Chengdu, Sichuan, China. The trial was registered in the Chinese Clinical Trial Registry (ChiCTR1900026606, date of registration: 2019-10-16) prior to patient enrollment. The study protocol followed the CONSORT guidelines. The study protocol was performed in the relevant guidelines. Written informed consent was obtained from all patients.
: Not applicable.
: The authors declare that they have no competing interests.